Pharmaceuticals

Global and China Drugs for Treatment of Primary Hypercholesterolemia Research Report 2015 to 2021

  • QYR604258
  • 123 Pages
  • June 2016
  • Pharmaceuticals
China Drugs for Treatment of Primary Hypercholesterolemia Research Report 2015 to 2021
Hard Copy: 2750 USD
PDF Copy (single user): 2750 USD
Enterprise wide License: 5500 USD
Pages: 123
Tables and Figures: 156
Published Date: June 2016
Publisher: QYR Medical Research Center
Contact: Mr. Zhang Dong 86-10-82945717; 86-13811796901, sales@qyresearch.com

The global Drugs for Treatment of Primary hypercholesterolemia market was valued at USD 78.47 Billion in 2015, and is projected to reach USD 86.92 Billion by 2021, at a CAGR of 2.07% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Primary hypercholesterolemia in Global and China market, including Rosuvastatin Calcium Tablets, Atorvastatin Calcium Tablets, Simvastatin Tablets, Simvastatin Pills, Fluvastatin Sodium Capsules, Pravastatin Sodium Capsule, Rosuvastatin Calcium Capsules, Atorvastatin Calcium Capsules and Pravastatin Sodium Tablets, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Primary hypercholesterolemia in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.The sales mainly credit at Crestor, which took up 63.94% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Primary hypercholesterolemia, revenue and market share, for key manufacturers. The main manufacturers as follows: AstraZeneca, Pfizer, Lek Pharmaceuticals, MSD TECHNOLOGY SINGAPORE PTE LTD, Merck Sharp & Dohme (Australia) Pty. Ltd., Novartis, Bristol-Myers Squibb, Simcere, SL PHARM, Cinmed Pharmaceutical, HISUN, Livzon Pharmaceutical Group and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Primary hypercholesterolemia in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Primary hypercholesterolemia in major applications.

With 123 pages, 156 charts and eight chapters, to display the market present situation and future, clearly and deeply.


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Cancer Therapeutics and Biotherapeutic Market (Technology, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

Cancer is one of the leading causes of death worldwide. According to the World Health Organization, about 8.2 million deaths occurred in 2012 due to cancer. The most ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Pharmacy Automation Systems Market (Application, End-User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Pharmacy automation system involves the automation of workflow tasks in the fields of pharmacy or healthcare, such as object counting, prescription management, compound preparation, dispensing, medication packaging and inventory management. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

RNA-Based Therapeutics Asia-Pacific Market Research Report, 2014 - 2021

The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics play a crucial role in providing ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Transdermal Drug Delivery Systems Market (Application, Technology and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Transdermal route is a promising alternative for oral and injectable drug delivery wherein skin is the primary site for drug administration. This drug delivery system offers certain benefits, such as ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Retractable Safety Syringe Market (Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast 2013 - 2020

Safety syringes are syringes developed with a safety mechanism to prevent needle stick and other injuries. The needle on a safety syringe can be detachable or permanently attached. The emphasis ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>